This month's article in "Innovations in Hepatitis Elimination" series is "Impact of COVID-19 Response on Hepatitis Prevention Care and Treatment: Results From Global Survey of Providers and Program Managers" from the Coalition for Global Hepatitis Elimination (CGHE).
From August to October 2020, CGHE surveyed clinicians and program managers to assess the mitigation strategies deployed to reduce SARS-CoV-2 transmission and the changes in access to hepatitis testing and treatment services. In this interview, Dr. Ward, Director of the Coalition, will review the key findings from the survey and also speak with some of the survey respondents who will describe their experience in delivering hepatitis services during the pandemic, including the challenges they faced and the mitigation strategies they found effective in maintaining access to care for their patients.
Survey respondents who will share their experiences include:
Ashina Singh (USA) - Dr. Ashina Singh is a board-certified physician in gastroenterology and transplant hepatology and practices in Detroit, MI as an affiliate of the Henry Ford Health System.
Wendy Spearman (South Africa) - Dr. Wendy Spearman is Head of the Division of Hepatology, Department of Medicine, Faculty of Health Sciences at the University of Cape Town.
Bernadette Lettner (Canada) - Bernadette Lettner is a treatment RN with the Toronto Community Hepatitis C Program (TCHCP).
Rui Marinho (Portugal) - - Dr. Rui Tato Marinho is the Head of the Department of Gastroenterology and Hepatology at Saint Mary's Hospital and a Professor at the Medical School of Lisbon.
Find our more about the speakers here: https://www.globalhep.org/webinars/impact-covid-19-response-hepatitis-prevention-care-and-treatment-results-global-survey